secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-02-14T23:59:59+00:00
Accession:  0001731122-24-000246
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 2.01, 8.01, 3.02, 5.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro completes acquisition of GEDi Cube; issues 70.8M shares, renames to Renovaro Inc.
--------------------------------------------------------------------------------

- Completed acquisition of GEDi Cube for 70,834,183 shares; Sellers hold ~49% of outstanding shares after closing.
- Series A Convertible Preferred Stock automatically converted into 5,610,100 shares; total shares outstanding now 143,668,372.
- Director Henrik Grønfeldt-Sørensen resigned; Karen Brink (GEDiCube Chief Growth Officer) appointed to board effective closing.
- Company renamed to Renovaro Inc.; CEO Mark Dybul leads combined entity with GEDiCube CEO as President.
- Unaudited pro forma financials filed; acquisition accounted for as business combination using purchase method.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000246/0001731122-24-000246-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224000246/e5418_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-000246

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer